In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification-Reference-Cited by-同舟云学术

In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification

Published:2023-10 Issue:4 Volume:62 Page:106935
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Gato Eva,Guijarro-Sánchez Paula,Alonso-García Isaac^ORCID,Pedraza-Merino Rosa,Conde Adrian^ORCID,Lence Emilio,Rumbo-Feal Soraya^ORCID,Peña-Escolano Andrea^ORCID,Lasarte-Monterrubio Cristina^ORCID,Blanco-Martín Tania,Fernández-González Ana,Fernández-López M. del Carmen,Maceiras Romina,Martínez-Guitián Marta,Vázquez-Ucha Juan Carlos^ORCID,Martínez-Martínez Luis^ORCID,González-Bello Concepción^ORCID,Arca-Suárez Jorge^ORCID,Beceiro Alejandro,Bou Germán

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference42 articles.

1. Management of KPC-producing Klebsiella pneumoniae infections;Bassetti;Clin Microbiol Infect,2018

2. Carbapenem resistance in Enterobacteriaceae: here is the storm!;Nordmann;Trends Mol Med,2012

3. Characterisation of the first ongoing outbreak due to KPC-3-producing Klebsiella pneumoniae (ST512) in Spain;López-Cerero;Int J Antimicrob Agents,2014

4. Ceftazidime/avibactam and ceftolozane/tazobactam: second-generation β-lactam/β-lactamase inhibitor combinations;van Duin;Clin Infect Dis,2016

5. Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-lactamases;Lahiri;Antimicrob Agents Chemother,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypervirulent and carbapenem-resistant Klebsiella pneumoniae: A global public health threat;Microbiological Research;2024-11

2. In-vitro multiparametric analysis of imipenem resistance in bacteria caused by acquisition of foreign DNA and natural mutations;Journal of Environmental Chemical Engineering;2024-10

3. Complex evolutionary trajectories in vivo of two novel KPC variants conferring ceftazidime-avibactam resistance;International Journal of Antimicrobial Agents;2024-09

4. Reversion of KPC-114 to KPC-2 in ceftazidime-avibactam- resistant/meropenem-susceptible Klebsiella pneumoniae ST11 is related to low mutation rates;Microbiology Spectrum;2024-08-27

5. In Vitro Resistance-Predicting Studies and In Vitro Resistance-Related Parameters—A Hit-to-Lead Perspective;Pharmaceuticals;2024-08-15